OFIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Orthofix Medical Inc (OFIX) is not a strong buy at this moment for a beginner investor with a long-term strategy. The stock is currently in a bearish technical trend, with no significant positive catalysts or trading signals to support an immediate purchase. Additionally, the company's financial performance shows weak profitability and declining net income, which raises concerns about its long-term growth potential.
The technical indicators for OFIX suggest a bearish trend. The MACD is negative and expanding, RSI indicates the stock is oversold, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 12.011, with resistance levels at 13.833 and 14.396.
The company's gross margin increased by 4.03% YoY in Q4 2025, indicating some operational efficiency improvements.
Analysts have lowered price targets recently, and there are no recent positive news or trading trends from insiders or hedge funds. The stock's short-term and long-term price trends are bearish, with a projected decline in the next month (-15.91%).
In Q4 2025, revenue increased by 1.97% YoY to $219.91 million, but net income dropped significantly to -$2.22 million (-92.38% YoY), and EPS fell to -0.06 (-92.00% YoY). Gross margin improved to 69.7%, up 4.03% YoY, but the overall financial performance indicates weak profitability.
Analysts have recently lowered their price targets for OFIX, with Stifel reducing it to $18, Canaccord to $20, and Barrington to $17, while maintaining Buy or Outperform ratings. TD Cowen initiated coverage with a Hold rating and a $14 price target, citing the need for evidence of accelerating sales for the stock to perform well.
